Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06455072
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-06-06
Brief Title:
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Organization Data
Organization:
Fujian Cancer Hospital
Class:
OTHER_GOV
Study ID:
K2022173
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fujian Cancer Hospital
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Zhangzhou Municipal Hospital of Fujian Province | OTHER |